Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig W Ritchie

Showing results (1-10 of 147) with videos related to

Pageof 15
Sort By:
BMJ Open|November 21, 2012
The PREVENT study: a prospective cohort study to identify mid-life biomarkers of late-onset Alzheimer's diseaseCraig W Ritchie, Karen Ritchie
International Review of Psychiatry (Abingdon, England)|January 16, 2014
The PREVENT research programme--a novel research programme to identify and manage midlife risk for dementia: the conceptual frameworkCraig W Ritchie, Katie Wells, Karen Ritchie
The Lancet. Healthy Longevity|November 10, 2022
Science disconnected: the translational gap between basic science, clinical trials, and patient care in Alzheimer's diseaseSarah Gregory, Stina Saunders, Craig W Ritchie
Therapeutic Advances in Chronic Disease|December 20, 2012
Latest Advances on Interventions that May Prevent, Delay or Ameliorate DementiaDanielle Wilson, Ruth Peters, Karen Ritchie, et al.
Expert Opinion on Investigational Drugs|November 30, 2004
Metal-protein attenuating compounds and Alzheimer's diseaseCraig W Ritchie, Ashley I Bush, Colin L Masters
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 14, 2004
Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer diseaseCraig W Ritchie, David Ames, Tim Clayton, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 12, 2020
Performance validity test failure in clinical populations-a systematic reviewLaura McWhirter, Craig W Ritchie, Jon Stone, et al.
Alzheimer'S Research & Therapy|March 20, 2015
Dementia trials and dementia tribulations: methodological and analytical challenges in dementia researchCraig W Ritchie, Graciela Muniz Terrera, Terence J Quinn
Methods in Molecular Biology (Clifton, N.J.)|March 8, 2018
Systems Biology Methods for Alzheimer's Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and TrialsJuan I Castrillo, Simone Lista, Harald Hampel, et al.
Drugs & Aging|December 24, 2011
Health state values for use in the economic evaluation of treatments for Alzheimer's diseaseJames Shearer, Colin Green, Craig W Ritchie, et al.
Pageof 15

Showing results (1-10 of 147) with videos related to

Sort By:
Pageof 15
BMJ Open|November 21, 2012
The PREVENT study: a prospective cohort study to identify mid-life biomarkers of late-onset Alzheimer's diseaseCraig W Ritchie, Karen Ritchie
International Review of Psychiatry (Abingdon, England)|January 16, 2014
The PREVENT research programme--a novel research programme to identify and manage midlife risk for dementia: the conceptual frameworkCraig W Ritchie, Katie Wells, Karen Ritchie
The Lancet. Healthy Longevity|November 10, 2022
Science disconnected: the translational gap between basic science, clinical trials, and patient care in Alzheimer's diseaseSarah Gregory, Stina Saunders, Craig W Ritchie
Therapeutic Advances in Chronic Disease|December 20, 2012
Latest Advances on Interventions that May Prevent, Delay or Ameliorate DementiaDanielle Wilson, Ruth Peters, Karen Ritchie, et al.
Expert Opinion on Investigational Drugs|November 30, 2004
Metal-protein attenuating compounds and Alzheimer's diseaseCraig W Ritchie, Ashley I Bush, Colin L Masters
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 14, 2004
Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer diseaseCraig W Ritchie, David Ames, Tim Clayton, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 12, 2020
Performance validity test failure in clinical populations-a systematic reviewLaura McWhirter, Craig W Ritchie, Jon Stone, et al.
Alzheimer'S Research & Therapy|March 20, 2015
Dementia trials and dementia tribulations: methodological and analytical challenges in dementia researchCraig W Ritchie, Graciela Muniz Terrera, Terence J Quinn
Methods in Molecular Biology (Clifton, N.J.)|March 8, 2018
Systems Biology Methods for Alzheimer's Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and TrialsJuan I Castrillo, Simone Lista, Harald Hampel, et al.
Drugs & Aging|December 24, 2011
Health state values for use in the economic evaluation of treatments for Alzheimer's diseaseJames Shearer, Colin Green, Craig W Ritchie, et al.
Pageof 15